Member Info for MIKODX

Demand for the UK-RTC rapid tests is growing rapidly, with the market likely to exceed $10 billion globally.

https://www.yorkpress.co.uk/news/18523255.york-covid-anti-body-test-firm-abingdon-health-expanding-new-jobs/

The consortium are saying the test is highly accurate, but that's what they said the last time and we all know how that turned out. The Consortium know what's required this time round so hopefully they've got it right and not just ramping up.

Truth is no one can guarantee immunity once you catch it, the disease just has not been around long enough. We will get a better picture after at least a year. Cases were popping up in China of people catching it twice, but this was because China were using antibody tests with low sensitivity and specificity which was producing false positives. This is what the UK Govt is trying to avoid, which is why they are demanding high sensitivity and specificity from the RTC anitbody tests.

The UK next. Wont be long now before DF, then watch this go through the roof.

https://www.ulster.ac.uk/news/2020/june/ulster-university-launches-new-study-exploring-covid-19-exposure-and-immunity-in-ni

Tests are being done on the RTC lateral flow device as we speak. Time to load up.

https://www.ulster.ac.uk/news/2020/june/ulster-university-launches-new-study-exploring-covid-19-exposure-and-immunity-in-ni

Trickymatters I said correct me if I'm wrong, not abuse if I'm wrong. My previous comment was more of a question than a statement you Ignorant ....hole.

Dodge100 I've just read the RNS again and the way I understand it the Fundraising is split into two parts.

· Placing of 19,950,000 New Ordinary Shares ("Placing Shares"), split between 7,515,350 First Admission Placing Shares, and 12,434,650 Second Admission Placing Shares at the Issue Price to raise gross proceeds of £7.98 million.

The First Admission shares(which includes private investors only) will be sold on Thursday 25th.

· Application will be made to the London Stock Exchange for the First Admission Placing Shares to be admitted to trading on AIM on 25 June 2020 ("First Admission").

The Second Admission shares (Open Shares, which includes current shareholders) will be sold on 13th July pending a GM. These shares will be sold at 1:20 for current stakeholders.

· Subject to passing of the Resolutions and the General Meeting, application will be made to the London Stock Exchange for the Second Admission Placing Shares, Subscription Shares and Open Offer Shares to be admitted to trading on AIM on 13 July 2020 ("Second Admission").

So the way I understand it the SP will drop to 40p as of 13th July. Feel free to correct me if I'm wrong.

ChrisToffer thanks, I stand corrected. I must point out that this is what initially made me stop investing in SNG. The hospital patients started dosing on 23/03/2020. I saw on youtube the CEO said that results should come through in 8 weeks, which would have been mid May. When mid May came and went with no news I decided to stop investing in SNG although I held my original shares just in case. Now I'm so glad I held and topped up some more. If this stays under 50 I will be looking to top up again as soon as I can sell off some other lazy shares. Good times ahead.

Dodge100 what shares are being issued at 40p? I thought that starts on Thursday, or is it after the GM?

So the Placement and the Delayed shares has made sure the SP stays under 50. So what about the holders that bought in the 50s and want to sell and come in lower, they don't get that chance? The delayed shares guarantees the SP doesn't rise above 50. Daylight robbery if you ask me.

I noticed this on Friday and yesterday and thought that was very strange. Surely they are not allowed to do this.

According to the Govt website 942 people died last week from covid 19. The inhaler began being rolled out Nationwide 19th June last Friday. It will be interesting to see the number of deaths this week. So far it has been very low. If it stays this way then we are onto a sure winner here.

upupandawaybby, treatment improves a condition and improves the patient's quality of life while they still have the disease. A cure totally eradicates the disease. If results show that all or the vast majority of people recover from covid using the inhaler, then it is basically a cure.

The results for the patients that were treated in the hospital setting should come through any day now. If you read between the lines the results must be good for them to expand it Nationwide. The fact that this is being used by the NHS is also a big plus. If it's found to greatly improve lung function, then this could get approved very quickly. Synairgen are firmly in the driving seat.

Yes Not2sure, I'm heavily invested in the Covid stocks. It would be stupid not to :)

Correct me if I'm wrong but the other day on the daily coronavirus briefings, they were saying that a group in Southampton were making substantial progress and are close to a cure for covid 19. I straight away thought it was Synairgen but was told that it was actually trials that were being done at Southampton University. After reading the below it is clear that Synairgen are the group that is behind the trials that are being done by Southampton University. Take a look.

https://www.dailymail.co.uk/news/article-8438109/Inhaler-lets-coronavirus-victims-treat-trialled-UK.html

This is fantastic news.

https://www.dailymail.co.uk/news/article-8438109/Inhaler-lets-coronavirus-victims-treat-trialled-UK.html

Check the infection rates on the weekly summary reports. Infection rates still high.

I don't know why the government is telling everyone the infection rates are coming down. Check out the surveillance reports and see for yourself.

https://www.gov.uk/government/publications/national-covid-19-surveillance-reports

unvrkw - It was Omega that expanded their manufacturing capabilities not Mologic.